Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.

Pirttila T, Mehta PD, Frey H, Wisniewski HM.

Neurobiol Aging. 1994 May-Jun;15(3):313-7.

PMID:
7936055
2.

The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.

Potter H, Wefes IM, Nilsson LN.

Neurobiol Aging. 2001 Nov-Dec;22(6):923-30. Review.

PMID:
11755000
3.

Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing.

Blennow K, Vanmechelen E.

J Neural Transm Suppl. 1998;53:223-35. Review.

PMID:
9700660
4.

Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's disease.

Galasko D.

J Neural Transm Suppl. 1998;53:209-21. Review.

PMID:
9700659
5.

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid.

Teunissen CE, de Vente J, Steinbusch HW, De Bruijn C.

Neurobiol Aging. 2002 Jul-Aug;23(4):485-508. Review.

PMID:
12009495
6.

Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer's disease.

Abraham CR.

Neurobiol Aging. 2001 Nov-Dec;22(6):931-6. Review.

PMID:
11755001
7.

Biological markers for the clinical diagnosis of Alzheimer's disease.

Arai H.

Tohoku J Exp Med. 1996 Jun;179(2):65-79. Review.

8.

Potential inflammatory biomarkers in Alzheimer's disease.

Mrak RE, Griffin WS.

J Alzheimers Dis. 2005 Mar;8(4):369-75. Review.

PMID:
16556968
9.
10.

Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies.

Ventriglia M, Bucossi S, Panetta V, Squitti R.

J Alzheimers Dis. 2012;30(4):981-4. doi: 10.3233/JAD-2012-120244. Review.

PMID:
22475798
11.

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.

LleĆ³ A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B.

Nat Rev Neurol. 2015 Jan;11(1):41-55. doi: 10.1038/nrneurol.2014.232. Review.

PMID:
25511894
12.

Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Noelker C, Hampel H, Dodel R.

Mol Diagn Ther. 2011 Apr 1;15(2):83-102. doi: 10.2165/11534870-000000000-00000. Review.

PMID:
21623645
13.

[Alpha 1-antichymotrypsin (ACT)].

Mashige F, Miyake K.

Nihon Rinsho. 1995 Feb;53 Su Pt 1:198-202. Review. Japanese. No abstract available.

PMID:
8753403
Items per page

Supplemental Content

Support Center